Patients with cancer desire more communication about medical imaging risks, benefits
the ONA take:
According to a new study published online in the journal Radiology, researchers from Memorial Sloan Kettering Cancer Center in New York City, New York, have found that patients with cancer desire more information from health care professionals about medical imaging tests that use radiation.
For the study, researchers talked to 30 people who had undergone medical imagine exams to assess their understanding of the risks and benefits associated with different medical imaging procedures as well as what they expected health care professionals to communicate about those benefits and risks.
Results showed that most participants were highly aware of risks linked with ionizing radiation exposure, including the risk of future cancer; however, participants still wanted their own doctor to communicate this information to them.
Participants also reported wanting to be offered information about the reasons for certain testing and testing intervals, as well as alternative approaches. Those who sought more information turned to the Internet to answer their own questions.
The findings suggest that better communication about the benefits and risks of various medical imaging tests is needed as medical care becomes more patient-centered.
Patients with cancer desire more information from health care professionals about medical imaging tests that use radiation.
- Immunotherapy May Benefit Some Patients with Papillary Thyroid Carcinoma
- New Study Questions Standard Dosage for Treating Metastatic Non-Small Cell Lung Cancer
- Clinical Trials May Benefit Oncology Patients
- Breast Cancer Overdiagnosis Also a Result of Screening Mammography Programs
- Prostate-specific PET and CT Imaging Improves Detection of Disease and Patient Care
- Survivorship Care Plans: Providing A Blueprint for Health Care After Cancer
- Multifaceted Role of the Nurse Navigator Includes Palliative, Supportive Care
- Cancer Recurrence Fear Reduced by Novel Psychological Intervention
- Patient Navigators Found to Boost Lung Cancer Screening Rates
- Breast Cancer Diagnosis and Nurse Navigation Survey
- Novel 3D Marker Reduces Radiation, Improves Cosmesis in Breast Conserving Surgery
- Rates at Some Milestones May Indicate Clinical Trial Results for Immunotherapeutics
- Cancer Risks for BRCA1/2 Mutation Carriers Determined by Age, Family History, Mutation Location
- Long-Term Use of TPO Receptor Agonist Safe in CLL-Associated Immune Thrombocytopenia
- Savolitinib Active, Tolerable in Subset of Advanced Papillary Renal Cell Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|